Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia

PURPOSE: Allogeneic hematopoietic cell transplantation (HCT) after high-dose conditioning regimens imposes prohibitively high risks of morbidity and mortality for patients with high-risk acute myeloid leukemia (AML) who are older or have comorbid conditions. Here, we examined outcomes after nonmyelo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gyurkocza, Boglarka, Storb, Rainer, Storer, Barry E., Chauncey, Thomas R., Lange, Thoralf, Shizuru, Judith A., Langston, Amelia A., Pulsipher, Michael A., Bredeson, Christopher N., Maziarz, Richard T., Bruno, Benedetto, Petersen, Finn B., Maris, Michael B., Agura, Edward, Yeager, Andrew, Bethge, Wolfgang, Sahebi, Firoozeh, Appelbaum, Frederick R., Maloney, David G., Sandmaier, Brenda M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2010
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903320/
https://ncbi.nlm.nih.gov/pubmed/20439626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.27.1460
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados